Who has invested in Primmune Therapeutics?

Bioqube Ventures, Oberland Capital, Samsara Biocapital are named among the investors backing Primmune Therapeutics.

Primmune Therapeutics Funding: $23M Raised, Series B (2026)

Primmune Therapeutics funding overview

Primmune Therapeutics is a Biotech company based in San Diego. Primmune Therapeutics has raised $23M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in January 2026. The round record for Primmune Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Bioqube Ventures, Oberland Capital, Samsara Biocapital. 3 distinct backers are named across the disclosed rounds.

Primmune Therapeutics at a glance

Total raised: $23M
Latest round: Series B
Latest round date: January 2026
Industry: Biotech
Headquarters: San Diego
Notable investors: Bioqube Ventures, Oberland Capital, Samsara Biocapital

Frequently asked about Primmune Therapeutics funding

How much has Primmune Therapeutics raised?: Primmune Therapeutics has raised $23M in total disclosed funding across the rounds on record.
Who has invested in Primmune Therapeutics?: Bioqube Ventures, Oberland Capital, Samsara Biocapital are named among the investors backing Primmune Therapeutics.
What was the latest Primmune Therapeutics funding round?: The most recent disclosed round is a Series B, announced in January 2026.
Where is Primmune Therapeutics based?: Primmune Therapeutics is based in San Diego.
What sector does Primmune Therapeutics operate in?: Primmune Therapeutics is tracked under Biotech from San Diego, with $23M in disclosed funding.
When did Primmune Therapeutics last raise?: The last disclosed Primmune Therapeutics round closed in January 2026 at Series B.

Round data for Primmune Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in San Diego and backer lists below.

Primmune Therapeutics Funding: $23M Raised, Series B (2026)

Primmune Therapeutics funding overview

Primmune Therapeutics at a glance

Frequently asked about Primmune Therapeutics funding

Companies related to Primmune Therapeutics (38)

Browse related funding lists (6)